Dave Fletcher

Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015.

Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015.

Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015.

Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015.

Part of Society for Endocrinology, Bioscientifica Ltd. is a British company that conducts research on the side effects of steroid creams. The company is based in Bristol, UK. The company found that women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, a serious condition that causes extreme fatigue and can even lead to death. Bioscientifica suggests that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health. The company also conducted a study on increasing the amount of appetite hormone, leptin, in the brain which causes long-term weight loss without the bone weakening which is a common side effect of weight loss by dieting. Ian Russell has been the CEO of the company since 2015.